CA1032962A - 2,6-disubstituted phenyl-aminoguanidine compounds - Google Patents

2,6-disubstituted phenyl-aminoguanidine compounds

Info

Publication number
CA1032962A
CA1032962A CA213,351A CA213351A CA1032962A CA 1032962 A CA1032962 A CA 1032962A CA 213351 A CA213351 A CA 213351A CA 1032962 A CA1032962 A CA 1032962A
Authority
CA
Canada
Prior art keywords
disubstituted phenyl
aminoguanidine compounds
aminoguanidine
compounds
disubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA213,351A
Other languages
English (en)
French (fr)
Other versions
CA213351S (en
Inventor
Harm J. Panneman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzona Inc
Original Assignee
Akzona Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzona Inc filed Critical Akzona Inc
Application granted granted Critical
Publication of CA1032962A publication Critical patent/CA1032962A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA213,351A 1973-11-09 1974-11-08 2,6-disubstituted phenyl-aminoguanidine compounds Expired CA1032962A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7315350A NL7315350A (nl) 1973-11-09 1973-11-09 Nieuwe aminoguanidine verbindingen.

Publications (1)

Publication Number Publication Date
CA1032962A true CA1032962A (en) 1978-06-13

Family

ID=19819967

Family Applications (1)

Application Number Title Priority Date Filing Date
CA213,351A Expired CA1032962A (en) 1973-11-09 1974-11-08 2,6-disubstituted phenyl-aminoguanidine compounds

Country Status (17)

Country Link
US (1) US3972932A (enExample)
JP (1) JPS5546389B2 (enExample)
AR (1) AR205358A1 (enExample)
BE (1) BE822019A (enExample)
CA (1) CA1032962A (enExample)
CH (1) CH616656A5 (enExample)
DE (1) DE2452691A1 (enExample)
DK (1) DK138791B (enExample)
ES (1) ES431775A1 (enExample)
FI (1) FI62064C (enExample)
FR (1) FR2250521B1 (enExample)
GB (1) GB1487852A (enExample)
HU (1) HU171856B (enExample)
IE (1) IE40409B1 (enExample)
NL (1) NL7315350A (enExample)
SE (1) SE420720B (enExample)
ZA (1) ZA746701B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141992A (en) * 1975-08-22 1979-02-27 American Cyanamid Company Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic agents
US4113776A (en) * 1976-04-15 1978-09-12 Hoffmann-La Roche Inc. 1-(2-Aminoethyl)-3-(2,6-dihalophenyl)guanidines
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
EP0175649B1 (de) * 1984-09-19 1991-01-02 Ciba-Geigy Ag Substituierte Carbodiimide
ZA857153B (en) * 1984-09-19 1986-05-28 Ciba Geigy Ag Substituted carbodiimides
IE910719A1 (en) 1990-03-02 1991-09-11 Oregon State Tri- and tetra-substituted guanidines and their use as¹excitatory amino acid and antagonists
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
EP0940139B1 (en) * 1991-02-08 2005-02-02 Scion Pharmaceuticals, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
JP3610368B2 (ja) * 1993-05-27 2005-01-12 セネス リミティド 治療用置換グアニジン
WO1995014461A1 (en) * 1993-11-23 1995-06-01 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
AU1912595A (en) 1994-02-03 1995-08-21 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
JP4739695B2 (ja) * 2004-06-07 2011-08-03 株式会社日本ファインケム 5−アミノ―1―置換―1,2,4―トリアゾールの製造方法、及び該製造方法で得られるトリアゾール誘導体
JP4564786B2 (ja) * 2004-06-07 2010-10-20 株式会社日本ファインケム 1−置換―1―アミノグアニジン又はその塩、及びこれらの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB800869A (en) * 1955-09-28 1958-09-03 Ici Ltd Substituted amino-guanidines
NL7011683A (enExample) * 1970-08-07 1972-02-09

Also Published As

Publication number Publication date
ZA746701B (en) 1975-11-26
FR2250521A1 (enExample) 1975-06-06
DK579774A (enExample) 1975-07-07
CH616656A5 (enExample) 1980-04-15
JPS5546389B2 (enExample) 1980-11-22
FI324374A7 (enExample) 1975-05-10
IE40409B1 (en) 1979-05-23
US3972932A (en) 1976-08-03
FR2250521B1 (enExample) 1979-03-16
DK138791C (enExample) 1979-04-09
NL7315350A (nl) 1975-05-13
IE40409L (en) 1975-05-09
BE822019A (fr) 1975-05-09
AR205358A1 (es) 1976-04-30
HU171856B (hu) 1978-04-28
GB1487852A (en) 1977-10-05
SE420720B (sv) 1981-10-26
SE7414045L (enExample) 1975-05-12
ES431775A1 (es) 1976-12-16
JPS5077328A (enExample) 1975-06-24
DK138791B (da) 1978-10-30
FI62064B (fi) 1982-07-30
FI62064C (fi) 1982-11-10
DE2452691A1 (de) 1975-05-15

Similar Documents

Publication Publication Date Title
AU472475B2 (en) Polene compounds
CA1008860A (en) 1-phenyl-substituted 1,3,5-triazines
GB1487852A (en) 2,6-disubstituted phenyl-aminoguanidine compounds
AU477010B2 (en) 1,3-oxygenated &-oestratrienes
CA1026760A (en) 3,4-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
AU475890B2 (en) 1,4-dihydropyridine compounds
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
AU486669B2 (en) Novel 2,6-disubstituted phenyl-aminoguanidine compounds
CA1029726A (en) 1,8-naphthyridine-3-carboxamidetetrazolyl derivatives
AU478074B2 (en) 1,3-oxygenated s-oestratrienes
AU471999B2 (en) Substituted amino-acetylamino-benzophenone compounds
AU486943B2 (en) 2, 5 or 2, 6-disubstituted benzoxazoles
AU489033B2 (en) HERDICIDAL l, 3, 4-THIADIAZOL-2-YL-UREAS
AU480736B2 (en) 1, 2-diphenyl-ethane derivatives
AU477537B2 (en) 3, 4-DIHYDRO-2H-NAPHTHALIN-lone-5-OXYPROPYLPIPERAZINE DERIVATIVES
AU487239B2 (en) 2, 3-methanoprostaglandin derivatives
CA1024140A (en) 6-anilino-1,4,5-trihydroxyanthraquinones
AU483739B2 (en) Substituted trizzolo-1, 5-benzodiazephines
AU492554B2 (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives
AU479804B2 (en) New 6-aza-3h-1, 4-benzodia zepines
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
AU478213B2 (en) 17b- hydroxy-16, 16-dimethylester-4-en-3-one
AU486220B2 (en) 2,1,3-benzothiadiazin-(4)-one-2,2-doixides
AU482852B2 (en) Novel n-hydroxy-amidine compounds
AU466024B2 (en) Thienodiazepine compounds